Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Avai Bio (AVAI) Accumulated Depreciation & Amortization (2020 - 2022)

Avai Bio's Accumulated Depreciation & Amortization history spans 3 years, with the latest figure at $19592.0 for Q4 2022.

  • On a quarterly basis, Accumulated Depreciation & Amortization changed N/A to $19592.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $19592.0, a N/A change, with the full-year FY2022 number at $36527.0, down 32.27% from a year prior.
  • Accumulated Depreciation & Amortization hit $19592.0 in Q4 2022 for Avai Bio, up from $15767.0 in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for AVAI hit a ceiling of $53927.0 in Q1 2021 and a floor of $11567.0 in Q2 2020.
  • Historically, Accumulated Depreciation & Amortization has averaged $28272.0 across 3 years, with a median of $25823.0 in 2020.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: skyrocketed 37.91% in 2021 and later plummeted 32.27% in 2022.
  • Tracing AVAI's Accumulated Depreciation & Amortization over 3 years: stood at $40201.0 in 2020, then soared by 34.14% to $53927.0 in 2021, then crashed by 63.67% to $19592.0 in 2022.
  • Business Quant data shows Accumulated Depreciation & Amortization for AVAI at $19592.0 in Q4 2022, $15767.0 in Q3 2022, and $11942.0 in Q2 2022.